[go: up one dir, main page]

HUP9601524A3 - Prodrugs of paclytaxel-derivatives - Google Patents

Prodrugs of paclytaxel-derivatives

Info

Publication number
HUP9601524A3
HUP9601524A3 HU9601524A HUP9601524A HUP9601524A3 HU P9601524 A3 HUP9601524 A3 HU P9601524A3 HU 9601524 A HU9601524 A HU 9601524A HU P9601524 A HUP9601524 A HU P9601524A HU P9601524 A3 HUP9601524 A3 HU P9601524A3
Authority
HU
Hungary
Prior art keywords
paclytaxel
prodrugs
derivatives
Prior art date
Application number
HU9601524A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Company P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Company P filed Critical Bristol Myers Squibb Company P
Publication of HU9601524D0 publication Critical patent/HU9601524D0/hu
Publication of HUP9601524A2 publication Critical patent/HUP9601524A2/hu
Publication of HUP9601524A3 publication Critical patent/HUP9601524A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6551Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring
    • C07F9/65512Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
HU9601524A 1995-06-06 1996-06-05 Prodrugs of paclytaxel-derivatives HUP9601524A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46924795A 1995-06-06 1995-06-06

Publications (3)

Publication Number Publication Date
HU9601524D0 HU9601524D0 (en) 1996-07-29
HUP9601524A2 HUP9601524A2 (en) 1997-05-28
HUP9601524A3 true HUP9601524A3 (en) 2000-03-28

Family

ID=23863053

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9601524A HUP9601524A3 (en) 1995-06-06 1996-06-05 Prodrugs of paclytaxel-derivatives

Country Status (23)

Country Link
EP (1) EP0747385B1 (hu)
JP (1) JPH08337589A (hu)
KR (1) KR100375956B1 (hu)
CN (1) CN1066151C (hu)
AR (1) AR002756A1 (hu)
AT (1) ATE222259T1 (hu)
AU (1) AU695959B2 (hu)
CA (1) CA2176191A1 (hu)
CZ (1) CZ291516B6 (hu)
DE (1) DE69622933T2 (hu)
DK (1) DK0747385T3 (hu)
ES (1) ES2181824T3 (hu)
HU (1) HUP9601524A3 (hu)
IL (1) IL118526A (hu)
MX (1) MX9601994A (hu)
NO (1) NO315233B1 (hu)
NZ (1) NZ286723A (hu)
PL (1) PL187883B1 (hu)
PT (1) PT747385E (hu)
RU (1) RU2162082C2 (hu)
SG (1) SG72692A1 (hu)
TW (1) TW354293B (hu)
ZA (1) ZA964261B (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395770B1 (en) * 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
KR100615783B1 (ko) * 1997-05-27 2006-08-25 아이박스 리서치 인코포레이티드 탁산 치료를 받고 있는 인체를 제외한 포유동물의 과민증 또는 알러지 반응을 경감시키기 위한 방법 및 약학적 키트
US6204257B1 (en) * 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
WO2000048606A1 (en) * 1999-02-18 2000-08-24 Oxigene, Inc. Compositions and methods for use in targeting vascular destruction
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
AR030188A1 (es) 2000-02-02 2003-08-13 Univ Florida State Res Found Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
AU776122B2 (en) 2000-02-02 2004-08-26 Florida State University Research Foundation, Inc. C7 carbonate substituted taxanes as antitumor agents
US6916942B2 (en) 2000-02-03 2005-07-12 Bristol-Myers Squibb Company Process for the preparation of C-4 carbonate taxanes
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US7063977B2 (en) 2001-08-21 2006-06-20 Bristol-Myers Squibb Company Enzymatic resolution of t-butyl taxane derivatives
WO2003059255A2 (en) * 2001-12-21 2003-07-24 Guilford Pharmaceuticals, Inc. Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
KR20030049023A (ko) * 2001-12-13 2003-06-25 주식회사 코오롱 방사선 감작제용 파클리탁셀 유도체
WO2005087222A1 (en) 2004-03-05 2005-09-22 Florida State University Research Foundation, Inc. C7 lactyloxy-substituted taxanes
CN101146514B (zh) * 2005-02-18 2013-03-27 阿布拉西斯生物科学公司 用于整合入医疗装置的疏水性改善的药物
ITMI20050614A1 (it) * 2005-04-12 2006-10-13 Indena Spa Processo per la purificazione della 10-deacetilbaccatina iii dalla 10-deacetil-2-debenzoil-2-pentenoilbaccatina iii
RU2420239C1 (ru) * 2009-10-21 2011-06-10 Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения злокачественных забрюшинных опухолей у детей и подростков
EA032094B1 (ru) 2013-03-15 2019-04-30 Консерт Фармасьютикалс, Инк. Дейтерированный палбоциклиб
WO2015009889A1 (en) 2013-07-18 2015-01-22 Concert Pharmaceuticals, Inc. Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
SG11201803645PA (en) * 2015-11-19 2018-06-28 Biohaven Pharm Holding Co Ltd Amine prodrugs of pharmaceutical compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (ru) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Способ получения производных таксола
CA2111527C (en) * 1992-12-24 2000-07-18 Jerzy Golik Phosphonooxymethyl ethers of taxane derivatives
CA2129288C (en) * 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives

Also Published As

Publication number Publication date
NO962231D0 (no) 1996-05-31
CZ156396A3 (en) 1996-12-11
EP0747385A1 (en) 1996-12-11
AR002756A1 (es) 1998-04-29
HU9601524D0 (en) 1996-07-29
SG72692A1 (en) 2000-05-23
IL118526A0 (en) 1996-10-16
DE69622933T2 (de) 2003-04-24
CZ291516B6 (cs) 2003-03-12
PL187883B1 (pl) 2004-10-29
CA2176191A1 (en) 1996-12-07
DK0747385T3 (da) 2002-12-16
NZ286723A (en) 1998-03-25
CN1144805A (zh) 1997-03-12
ZA964261B (en) 1997-11-27
AU695959B2 (en) 1998-08-27
CN1066151C (zh) 2001-05-23
JPH08337589A (ja) 1996-12-24
ES2181824T3 (es) 2003-03-01
EP0747385B1 (en) 2002-08-14
MX9601994A (es) 1997-08-30
NO962231L (no) 1996-12-09
DE69622933D1 (de) 2002-09-19
ATE222259T1 (de) 2002-08-15
RU2162082C2 (ru) 2001-01-20
IL118526A (en) 2001-05-20
PT747385E (pt) 2002-11-29
NO315233B1 (no) 2003-08-04
AU5471896A (en) 1996-12-19
PL314637A1 (en) 1996-12-09
HUP9601524A2 (en) 1997-05-28
TW354293B (en) 1999-03-11
KR100375956B1 (ko) 2003-04-21
KR970000222A (ko) 1997-01-21

Similar Documents

Publication Publication Date Title
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
GB9526560D0 (en) Use of 2-Amino-Heterocycles
HU9601524D0 (en) Prodrugs of paklytaxel-derivatives
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
SG42329A1 (en) Use of phenylcyclohexylcarboxamides
GB2305006B (en) Manufacture of switchgear
PL323148A1 (en) Esters of crabapenemes
AP9600802A0 (en) Libricant
GB9526273D0 (en) New prodrugs
PL323141A1 (en) Esters of crabapenemes
AU129378S (en) TeleChipper
SG64924A1 (en) Inhibiting photodecompostion of 3-substituted-2- oxindoles
ZA962440B (en) Destressing of railtracks
GB9503734D0 (en) Manufacture of polyanlines
PL311976A1 (en) Closed-profile shape of double-o type
IL115554A0 (en) Earthquake-proofing of structures
AU1105P (en) DALESE Metrosideros excelsus
HRP950468A2 (en) New medicine - combination of components
GB9502747D0 (en) Insulants
HU9503668D0 (en) Attaching means of hooses
GB9512234D0 (en) Icositetrahedron shaped part
GB9510771D0 (en) Mask mate
AU130380S (en) Matting-tile
AU124825S (en) Quiltcover
AU124826S (en) Quiltcover